GenesyzeCase StudiesRWE for Service Transformation

RWE for Service Transformation

Leveraging big data to translate novel insights into sustainable change

Previous Study Next Study
evidence process improvement | Genesyze

Client Overview

NHS Community and Mental Healthcare Provider

 

 | Genesyze

Research Question (Client problem)

The local clinical commissioning groups (CCGs) were dissatisfied with the responsiveness of services provided to their patient populations and disappointed in the fragmented model of service delivery.  They wanted service improvement in the form of devolved multi-disciplinary teams or a new service provider.  However, services were already heavily vested in silos and staff were highly resistant to change, believing that traditional models worked best.

 | Genesyze

Solution (Our Service)

A postcode to ward mapping algorithm was used to link data from the providers activity database; socioeconomic data from the local government; health need assessment data from the general physician’s databases and provider service activity data.  A spatial/graphic mapping exercise highlighted areas of over provision and, more significantly, areas of under provision, in addition to stark inequities in provision across the geographic area.

 | Genesyze

Benefits (Results)

The evidence cemented the need for change in the hearts and minds of healthcare professionals across the service silos. Multi-disciplinary teams were established and targeted healthcare prevention and response programmes put in place to address unmet needs at CCG level.

 

 | Genesyze

Technology, Programming and software

SAS Graph

 | Genesyze

Insights

The data profiling methods deployed for this project are commonly used to generate consumer insights in the FMCG sector. Transference of methods from other sectors can deliver outstanding results in the healthcare sector, when an understanding of analytical and translational methods is combined.

 

REACH OUT TODAY

Arrange a call back...

Please leave this field empty.
curve
curve

Latest News

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.

Read more about the Integrated EU Network
Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out.  #theTOMs supporting Kidscan charity

Talk of Manchester Business Awards 2019. CEO, Colette Hamilton presents Best Digital Agency and Best Business Awards at the Talk of Manchester Business Awards on Thursday 6th December to a huge turn out. #theTOMs supporting Kidscan charity

Read
Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Colette Hamilton, CEO, speaker at sponsored event, Pharma Pricing & Market Access EU 2018. Talk title; Redefining HEOR practice to meet the needs of a 21st century healthcare system:the economist’s perspective.

Read
CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

CEO Colette Hamilton attends the UK’s first LinkedInLocal networking event in the North, at the UKFast headquarters. Exciting collaborations in Manchester, the heart of the UK’s Northern Tech Powerhouse

Read

This website uses cookies to give you the best experience. If you continue to use this site, we’ll assume that you’re happy to receive all cookies. View our Cookie Policy here.